Calamos Advisors’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Calamos Advisors’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-156,250	Closed	-$53.1K	–	1013
2024 Q1	$53.1K	Hold	156,250	–	–	﹤0.01%	822
2023 Q4	$31.6K	Hold	156,250	–	–	﹤0.01%	787
2023 Q3	$31.1K	Hold	156,250	–	–	﹤0.01%	798
2023 Q2	$24.1K	Hold	156,250	–	–	﹤0.01%	852
2023 Q1	$11.2K	Hold	156,250	–	–	﹤0.01%	1058
2022 Q4	$10K	Hold	156,250	–	–	﹤0.01%	1102
2022 Q3	$11K	Buy	+156,250	New	+$15.3K	﹤0.01%	1164

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Calamos Advisors's AONCW Position: Q2 2024 in Review

Calamos Advisors sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 156,250 shares — an estimated $53.1K sold.

Calamos Advisors first reported a position in AONCW in Q3 2022 and held it in 7 quarters. The position peaked at $53.1K in Q1 2024. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

Calamos Advisors reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
Calamos Advisors sold 156,250 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $53.1K.
Calamos Advisors first reported a position in American Oncology Network, Inc. Warrant in Q3 2022 and held it in 7 quarters.
Calamos Advisors's American Oncology Network, Inc. Warrant position peaked at $53.1K in Q1 2024.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.